Long-acting exenatide does not prevent cognitive decline in mild cognitive impairment: a proof-of-concept clinical trial.
Dei Cas A, Micheli MM, Aldigeri R, Gardini S, Ferrari-Pellegrini F, Perini M, Messa G, Antonini M, Spigoni V, Cinquegrani G, Vazzana A, Moretti V, Caffarra P, Bonadonna RC.
Dei Cas A, et al. Among authors: micheli mm.
J Endocrinol Invest. 2024 Apr 2. doi: 10.1007/s40618-024-02320-7. Online ahead of print.
J Endocrinol Invest. 2024.
PMID: 38565814